-
Greenfield RH. St. John's wort and major depression. Altern Med Alert 2005;8(4):46-47.
-
O'Mathuna DP. Tai chi for anxiety and depression. Altern Med Alert 2005;8(4):41-43.
-
Clinical trials for a male contraceptive that is a combination of progesterone and testosterone are expected to begin this year.
-
Given the importance of acute bacterial rhinosinusitis (ABRS), a commonly encountered outpatient infection, this article attempts to outline in evidence-based detail what the authors conclude to be optimal, risk-stratified, empiric treatment recommendations. In addition, this review identifies key clinical findings, resistance patterns, risk factors, coexisting conditions, and other clinical triggers supporting referral of patients with ABRS to an otolaryngologist for more invasive i.e., multimodal surgical and more intensive antimicrobial management strategies.
-
-
-
Use of risedronate in women 80 years and older reduced the incidence of vertebral fractures and was well tolerated.
-
African American women are far more likely to be infected with HIV than are white women and Hispanic women, a problem that has been growing, according to recent reports by the Centers for Disease Control and Prevention (CDC).
-
A spray-on birth control method for women recently has entered a Phase I clinical trial in which six women in Sydney, Australia, are using the new product as part of a study to determine whether the transdermal contraceptive can be used in spray formulation effectively.
-
The first male contraceptives to make it to the market likely will be hormonal-based birth control, similar to what has worked well for female contraceptives for the past four decades. However, there are serious difficulties with hormonal contraceptives for men, so the possibilities that are beginning to excite researchers working in the contraceptive field are the nonhormonal methods.